Find an expert
Our panel of editors are available for interview
Gareth Iacobucci
Assistant News Editor, The BMJ
Gareth Iacobucci reports mostly on issues of interest to doctors in the UK. He joined The BMJ in 2012. Prior to this Gareth was a reporter and editor at the general practioners’ title Pulse for five years.
Dr Jinghong Chen
Deputy Editor of General Psychiatry
Dr Jinghong Chen is the joint deputy editor of General Psychiatry. She is currently the principal investigator at Shanghai Key Laboratory of Psychotic Disorders and professor at Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine.
Professor John McMillan
Editor-in-Chief of the Journal of Medical Ethics
Professor John McMillan is a professor for the Bioethics Centre at the University of Otago. He is a member of the Advisory Committee for Assisted Reproductive Technology and the National Screening Advisory Committee, and has published broadly within bioethics.
Dr James Cave
Editor-in-Chief of the Drugs and Therapeutics Bulletin
Dr James Cave has been a GP for over 25 years. He currently works for Red Whale, providing courses for GP’s that take the latest research and demonstrate how it might be used in practice. James was awarded an OBE for services to medicine in 2009.
Dr Ellen Weber
Editor-in-Chief of Emergency Medicine Journal
Dr Ellen Weber is an emergency medicine physician in San Francisco, California. She received her medical degree from Harvard Medical School and has been in practice for more than 20 years. She has worked clinically in community, county and academic emergency departments, and conducts research in topics related to health policy. She is currently a Professor of Emergency Medicine and Vice Chair at UCSF.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.
